A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease

Lithium Chloride Alleviates Neurodegeneration Partly by Inhibiting Activity of GSK3β in a SCA3 Drosophila Model

(2013) Dan-Dan Jia et al.   CEREBELLUM

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease

(2012) Mahmoud A. Pouladi et al.   NEUROBIOLOGY OF DISEASE

Ataxia Rating Scales—Psychometric Profiles, Natural History and Their Application in Clinical Trials

(2011) Jonas Alex Morales Saute et al.   CEREBELLUM

Toward understanding Machado–Joseph disease

(2011) Maria do Carmo Costa et al.   PROGRESS IN NEUROBIOLOGY

Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride

(2010) Bumsup Kwon et al.   BRAIN RESEARCH

Progression Rate of Neurological Deficits in a 10-Year Cohort of SCA3 Patients

(2010) Laura Bannach Jardim et al.   CEREBELLUM

Responsiveness of different rating instruments in spinocerebellar ataxia patients

(2010) T. Schmitz-Hubsch et al.   NEUROLOGY

Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3β, β-Catenin, and Neurotrophin Cascades

(2009) Akihiko Wada   JOURNAL OF PHARMACOLOGICAL SCIENCES

Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment

(2008) Sophie Tezenas du Montcel et al.   BRAIN

A neurological examination score for the assessment of spinocerebellar ataxia 3 (SCA3)

(2008) C. Kieling et al.   EUROPEAN JOURNAL OF NEUROLOGY

SCA Functional Index: A useful compound performance measure for spinocerebellar ataxia

(2008) T. Schmitz-Hubsch et al.   NEUROLOGY

Lithium delays progression of amyotrophic lateral sclerosis

(2008) F. Fornai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Opposing Actions of Phosphatidylinositol 3-Kinase and Glycogen Synthase Kinase-3β in the Regulation of HSF-1 Activity

(2003) Gautam N. Bijur et al.   JOURNAL OF NEUROCHEMISTRY